TransMedics Group, Inc. Amortization of Debt Discount (Premium)
TransMedics Group, Inc. (TMDX) reported Amortization of Debt Discount (Premium) of $381.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2025-02-27
- TransMedics Group, Inc. amortization of debt discount (premium) for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- TransMedics Group, Inc. amortization of debt discount (premium) for the quarter ending 2022-09-30 was $12.00K, a 96.10% decline year-over-year.
- TransMedics Group, Inc. amortization of debt discount (premium) for the quarter ending 2022-06-30 was $141.00K, a 62.50% decline year-over-year.
- TransMedics Group, Inc. amortization of debt discount (premium) for the quarter ending 2022-03-31 was $228.00K, a 41.69% decline year-over-year.
- TransMedics Group, Inc. amortization of debt discount (premium) for fiscal 2022 was $381.00K, a 71.90% decline from fiscal 2021.
- TransMedics Group, Inc. amortization of debt discount (premium) for fiscal 2021 was $1.36M, a 113.88% increase from fiscal 2020.
- TransMedics Group, Inc. amortization of debt discount (premium) for fiscal 2020 was $634.00K.
- TransMedics Group, Inc. amortization of debt discount (premium) for fiscal 2019 was -$205.00K, a 2377.78% decline from fiscal 2018.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.00K derived: sum of 2 quarters · filed 2025-02-27 | $153.00K derived: sum of 3 quarters · filed 2025-02-27 | $381.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $153.00K derived: sum of 2 quarters · filed 2023-11-08 | $381.00K 10-Q · filed 2023-11-08 | $662.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $369.00K 10-Q · filed 2023-08-04 | $650.00K derived: sum of 3 quarters · filed 2024-02-27 | $958.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $228.00K 10-Q · filed 2023-05-04 | $509.00K derived: sum of 2 quarters · filed 2024-02-27 | $817.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.19M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $589.00K derived: sum of 2 quarters · filed 2024-02-27 | $965.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.36M 10-K · filed 2024-02-27 |
| 2021-09-30 | $308.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $684.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.07M 10-Q · filed 2022-11-04 | $1.41M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $767.00K 10-Q · filed 2022-08-03 | $1.10M derived: sum of 3 quarters · filed 2023-02-27 | $1.35M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $391.00K 10-Q · filed 2022-05-05 | $721.00K derived: sum of 2 quarters · filed 2023-02-27 | $976.00K derived: sum of 3 quarters · filed 2023-02-27 | $1.02M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $585.00K derived: sum of 2 quarters · filed 2023-02-27 | $633.00K derived: sum of 3 quarters · filed 2023-02-27 | $634.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $303.00K derived: sum of 2 quarters · filed 2021-11-09 | $304.00K 10-Q · filed 2021-11-09 | $235.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $49.00K 10-Q · filed 2021-08-06 | -$20.00K derived: sum of 3 quarters · filed 2021-05-07 | -$132.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-07 | -$68.00K derived: sum of 2 quarters · filed 2021-05-07 | -$180.00K derived: sum of 3 quarters · filed 2021-05-07 | |
| 2019-12-28 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$181.00K derived: sum of 2 quarters · filed 2021-03-11 | -$205.00K 10-K · filed 2021-03-11 | |
| 2019-09-28 | -$112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$136.00K 10-Q · filed 2019-11-08 | ||
| 2019-06-29 | -$24.00K 10-Q · filed 2020-08-07 | |||
| 2018-12-29 | $9.00K 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $9.00K 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $9.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $9.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |